Type 2/drug therapy
Arq Bras Endocrinol Metab vol.56 número2
... borative Drug Therapy Management Service showed that the introduction of insulin or dose adjustment in patients with DM type 2 improves glycemic control in patients with HbA1c levels over ...
8
Do patients value nutritional therapy? A quantitative study in type- 2 diabetes patients
... and drug therapy have in disease control, and also two questions in a five-point Likert scale were patients were asked to rate the quality (1-very poor, 5-very good) of both their overall eating habits and ...
6
Association between polypharmacy and the adherence to treatment in patients with diabetes
... mellitus type 2 through interview about the demographic and clinical data, drug therapy prescribed and adherence to ...prescribed therapy was reported by ...
8
Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin
... their therapy. Any file that showed any dietary indiscretion or drug misuse was not utilized in the ...A drug misuse was defined as any failure to take the prescribed drugs, as reported by the ...
6
Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
... The EMPA-REG OUTCOME trial showed that patients with T2D and established CVD disease who received empagliflozin versus placebo, had a lower rate of the primary composite of death from cardiovascular (CV) causes, ...
7
Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil
... (over 2 years) dual or triple therapy on genotypic outcomes in HIV-infected ...ARV therapy, detecting cross-resistance after failure to a first-line regimen is an important issue in the management of ...
15
Cancer, Photodynamic Therapy and Porphyrin-Type Derivatives
... after drug administration and also an almost complete clearance of the dimers from the serum and skin were detected after 1 ...Dim 2 and Dim 3 showed a higher selectivity for tumor localization ...
34
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.
... Methodology/ Principal Findings: HIV-infected patients $15 years of age who had failed protease inhibitor (PI)-based second-line ART (2 consecutive HIV RNA tests .1000 copies/ml on lopinavir/ritonavir, didanosine, ...
5
Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
... Normally, after coronary revascularization, patients with T2DM have an increased risk of Target Vessel Failure (TVF) and repeated revascularization due to a faster restenosis rate com- pared to patients without DM [18]. ...
15
Sao Paulo Med. J. vol.126 número4
... holds that the causative drug induces hyper- sensitivity as a result of abnormalities in the production and detoxification of its active me- tabolites. These abnormalities may be related to genetic predisposition, ...
2
Sulfonylurea: Personalized Medicine for Type 2 Diabetes
... in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Associa- tion and the European Association for the Study of Diabe- ...
2
An insight on the role of photosensitizer nanocarriers for Photodynamic Therapy
... (Figure 2) linked to the side chain of the copolymer by an imine bond (Figure ...O 2 quantum ...(Figure 2) on the AuNP nanoplatform (Figure 13b) revealed even better uptake efficiency by HeLa cells ...
30
METABOLIC SURGERY - CURE FOR TYPE 2 DIABETES
... bariatric surgery studies published from January 1990 until April 2006. Were reviewed the cases of patients in whom there was resolution of clinical manifestations and improvement in short-term (<2 years after ...
6
Drug interactions in Brazilian type 2 diabetes patients
... frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication ...579 type 2 diabetes mellitus patients from 12 health institutions in ...
8
Arq. Bras. Cardiol. vol.86 número5
... During fl ow analysis, venous return was occluded by infl ating a cuff around the upper arm to 40 mm Hg using a rapid cuff infl ator (Hokanson AG101, USA). Circulation to the hand was interrupted by infl ating another ...
8
TO Ogungbamigbe1 , O Ojurongbe
... Of the non-artemisinin combination regimens, AQ+SP has shown excellent antimalarial efficacy in most African studies, even in those from regions, such as east Africa, where levels of resistance to each compo- nent ...
6
Rev. Assoc. Med. Bras. vol.58 número3 en v58n3a08
... Objectives: To compare costs and clinical beneits of three additional therapies to met- formin (MF) for patients with diabetes mellitus type 2 (DM2). Methods: A discrete event simulation model was built to ...
8
Adherence of mental therapy for mental disorder patients to drug health treatmen
... about drug therapy, the individual must first have access to medication, and a lack of financial resources to purchase them restricts or precludes such access and greatly jeopardizes the continued use of ...
9
Psychological stress exerts effects on pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine response.
... Correlation between stress and liver inflammation Next, we compared virus load, virus genotypes, and ALT between these two group. As shown in table 1, no differences were observed between high and low stree/anxiety ...
7
J. Bras. Nefrol. vol.36 número1 suppl.1
... with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascu- lar events with Aranesp therapy (TREAT) ...
3